ABSTRACT
The development of a new drug involves different stages, during which a variety of test data are produced to determine its efficacy and non-toxicity. In the preclinical stage, the new chemical entity (NCE) is tested in animals to assess its pharma-codynamic, pharmacokinetic and toxicological profile. 1 Based on these results, clinical studies in human beings are carried out in three phases.
